DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Bateman ED, Guerreros AG, Brockhaus F. et al.
Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids.
Eur Respir J 2017;
50: 1700670
DOI: 10.1183/13993003.00670-2017.
We do not assume any responsibility for the contents of the web pages of other providers.